Kidney Disease

Semaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for people with type 2 diabetes

Doctors have transplanted a genetically modified pig kidney into a living human patient for the first time ever

In the U.S., a third of Americans are at risk of chronic kidney disease, and age is a major factor. More than half of Americans older than 75 are thought to have some sort of kidney damage. Here is what happens when you have it. Read the full five-part series in partnership with Undark: “Profit and Loss: America on Dialysis.”

Demand for healthy kidneys has long outstripped supply. But better testing and treatment are expanding the donor pool

Minority patients are diagnosed later, stay on dialysis longer and are added to transplant lists less quickly. Why?

Joint ventures between nephrologists and dialysis centers have expanded treatment. Critics ask: At what cost?

Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone's journey is the same

A new California law aims to curb what sponsors say is profiteering by dialysis centers. But are there any easy answers?

A new program could save lives in hospitals, where kidney injury is one of the most common causes of death

Doctors and patients are grappling with the unsettling finding that chronic use of popular heartburn medicines may be riskier than was thought

Blacks and whites on the transplant list are finally getting the organs at equal rates, although fewer blacks may make it onto the lists to begin with